European Medicines Agency Panel Backs Subcutaneous Sarclisa, Paving the Way for First Dual-Delivery Multiple Myeloma Therapy in the EU - For More Information Visit shorturl.at/27Anv #EMA @SanofiUS @sanofi #EMA #Multiple_Myeloma #MM #rare_Diseases #Orphan_Drugs